Novo Nordisk A/S
General Information
Identification Code: 29570313329-11
Website: [object Object]
Entity Form: Corporation
Registration Category: Companies & groups
Registration Date: 3/13/2010
Last Update: 6/27/2024
EP Accredited Number: 2
Mission & Interests
Goals: Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to serious chronic diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure the diseases we treat. We employ more than 60,000 people in 80 countries, and market our products in 170 countries. In 2023, we served more than 40 million patients worldwide. In 2023, we served more than 6 million patients in the EU. More than 30,000 of our employees are based in the EU. Novo Nordisk is committed to developing its business towards environmental, social and financial sustainability (the triple bottom line).The controlling stake in Novo Nordisk is owned by the Novo Nordisk Foundation. This is a non-profit institution, whose formal purpose is to provide a stable basis for its companies’ operations and to make contributions to scientific, humanitarian and social progress.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Climate action
- Digital economy and society
- Energy
- Environment
- Public health
- Research and innovation
- Trade
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: EU pharmaceutical-related policy, as well as broader health, environmental and business-related policy.
Communication Activities: The LinkedIn account of our CEO, Lars Fruergaard Jørgensen, may sometimes include content relevant to activities covered by the Register: https://www.linkedin.com/in/larsfruergaard/
Novo Nordisk sponsored Politico Brussels Playbook during the week of 20 February 2023
In November 2023, Politico Europe published sponsored content from EFPIA, authored by Lars Fruergaard Jørgensen in his role as EFPIA President: https://www.politico.eu/sponsored-content/the-future-for-europe-and-the-role-of-medical-innovation/
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Novo Nordisk A/SNovo Allé, 1
Post Code: 2880
City: Bagsværd
Country: DENMARK
Phone: [object Object]
EU Office
Address: Square de Meeûs 35
Post Code: 1000
City: Brussels
Country: BELGIUM
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 8
Members25 Percent: 2
Members50 Percent: 1
Members75 Percent: 2
Members: 13
Members F T E: 3.299999952316284
Info Members: A range of Novo Nordisk colleagues contribute their expertise to activities covered by the Register, directly or through trade associations. We have used 10% relevant working time as the threshold for including colleagues in our FTE calculations.
Structure
Structure Type: Structure
Is Member Of: n/a
Organisation Members: Novo Nordisk is member of:
- EFPIA - European Federation of Pharmaceutical Industries and Associations
- Danish Chamber of Commerce (Dansk Erhverv)
- Danish industry (Dansk industri)
- Science|Business Network